Cargando…
The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice
Monoamine transporters are the main targets of methamphetamine (METH). Recently, we showed that fluoxetine, a selective serotonin reuptake inhibitor (SSRI), decreased METH conditioned place preference (CPP), suggesting that serotonin transporter (SERT) inhibition reduces the rewarding effects of MET...
Autores principales: | Takamatsu, Y, Yamamoto, H, Hagino, Y, Markou, A, Ikeda, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137204/ https://www.ncbi.nlm.nih.gov/pubmed/21886565 http://dx.doi.org/10.2174/157015911795017236 |
Ejemplares similares
-
Absence of methamphetamine‐induced conditioned place preference in weaver mutant mice
por: Ikekubo, Yuiko, et al.
Publicado: (2020) -
Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
por: Luong, Thu-Lan T., et al.
Publicado: (2022) -
Serotonin Reuptake Inhibitor and Fluvoxamine-Induced Severe Hyponatremia in a 49-Year-Old Man
por: Gabriel, Adel
Publicado: (2009) -
Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation
por: Simsek, Abdulmuttalip, et al.
Publicado: (2014) -
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
por: Severino, Maurizio, et al.
Publicado: (2018)